South Korea Govt Proposes “Refund System” To Keep MNC Drug Prices Up, Provide Access To Patients
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's Ministry for Health, Welfare and Family Affairs is in pursuit of what it calls a "refunding system" under which multinational companies could sell their products at prices they want under the coverage of the local National Health Insurance System